APA aipamena

Song, Z., Wang, M., & Zhang, A. (2015). Alectinib: A novel second generation anaplastic lymphoma kinase (ALK) inhibitor for overcoming clinically-acquired resistance. Acta Pharm Sin B.

Chicago Style aipamena

Song, Zilan, Meining Wang, and Ao Zhang. "Alectinib: A Novel Second Generation Anaplastic Lymphoma Kinase (ALK) Inhibitor for Overcoming Clinically-acquired Resistance." Acta Pharm Sin B 2015.

MLA aipamena

Song, Zilan, Meining Wang, and Ao Zhang. "Alectinib: A Novel Second Generation Anaplastic Lymphoma Kinase (ALK) Inhibitor for Overcoming Clinically-acquired Resistance." Acta Pharm Sin B 2015.